Edition:
United Kingdom

People: Sawai Pharmaceutical Co Ltd (4555.T)

4555.T on Tokyo Stock Exchange

6,030JPY
4:42am BST
Change (% chg)

¥150 (+2.55%)
Prev Close
¥5,880
Open
¥5,950
Day's High
¥6,050
Day's Low
¥5,940
Volume
108,400
Avg. Vol
200,813
52-wk High
¥6,660
52-wk Low
¥4,880

Sawai, Kenzo 

Mr. Kenzo Sawai has been serving as Senior Managing Executive Officer, Director of Strategy Planning and Director in Sawai Pharmaceutical Co., Ltd., as well as President and Director in a subsidiary, Sawai America Inc., since June 27, 2017. He is also serving as Chairman of the Board in Upsher-Smith,Laboratories,LLC. He joined the Company in April 2001. His previous titles include Manager of Planning Group and Manager of Marketing Group in the Company. He used to work for a company that is under the new name Dainippon Sumitomo Pharma Co., Ltd.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --